Atlas Trials

Safety and Tolerability of NCP-IL-22BP mRNA in Advanced Solid Tumors

Clinical trial NCT07562815 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07562815
Sponsor
West China Hospital
Status
NOT_YET_RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
Cancer
Start date
2026-04-28
Primary completion
2027-04-28
Enrollment
9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.